Clinical Trial Update: Ropinirole PR Pharmacokinetics Study Among Chinese Healthy Subjects [Phase 1]

View source ↗

Summary

Phase 1 pharmacokinetics study of prolonged-release ropinirole in Chinese healthy subjects, sponsored by GlaxoSmithKline; study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Ropinirole PR (ropinirole)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Parkinson Disease | Phase 1 | Status: COMPLETED